Thank you, Madam Chair.
I would like to thank the witnesses for joining us here in person or through videoconference. Unfortunately, they will not be able to hear me.
As a Canadian, I am very proud of new technologies being developed in public health, including nanotechnology and genotechnology, if we can call it that. However, I am disappointed to see that, although we have the potential to be a leader in those two technologies, there are obstacles, from what I understood from your presentations.
My first question is for Dr. Voyer.
Based on the list I have before me, your work is mainly on basic research. In your view, how will the current government cuts affect tomorrow’s applied research? I think that there will probably be economic consequences. My fear is that the current cuts to fundamental research will have an impact on applied research, which in turn will have an impact on the access of Canadians to modern technologies.
The second part of my question has to do with funding. How do you see the balance between public and private funding, given that the purpose of private funding is to obtain dividends from applied research?
Thank you.